Verastem Oncology
Latest round
- Series C
Last raised
- Nov 2011
Total raised
- $56M
Investors
- 6
About Verastem Oncology
Founded in 2010 and based in Massachusetts, US, Verastem, Inc. doing business as Verastem Oncology operates as a biopharmaceutical company that engages in the development and commercialization of new medicines. The firm operates under the NASDQ stock exchange, under the ticker symbol VSTM.5 million to Verastem Oncology. Verastem Oncology focuses on developing therapies for RAS pathway-driven cancers, specifically targeting mutations in the KRAS, NRAS, and HRAS genes. Their core product, avutometinib (previously known as VS-6766), serves as a first-in-class RAF/MEK clamp designed to inhibit signaling through the RAS pathway by holding RAF and MEK in inactive complexes, effectively disrupting tumor growth. Verastem also explores combination therapies with other agents targeting parallel pathways, intending to enhance treatment efficacy. The company's products are primarily for oncology markets within North America, Europe, and select Asia-Pacific regions, catering to healthcare providers and patients seeking advanced cancer treatments.
Who invested in Verastem Oncology
6 investors across 3 rounds
See all investors in Verastem Oncology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Verastem Oncology
Who invested in Verastem Oncology?
Verastem Oncology has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Verastem Oncology raised?
Verastem Oncology has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Verastem Oncology last raise money?
Verastem Oncology's most recent round on record is a Series C, in Nov 2011.
What does Verastem Oncology do?
Founded in 2010 and based in Massachusetts, US, Verastem, Inc.
Where is Verastem Oncology headquartered?
Verastem Oncology is headquartered in Needham, US.
Which VCs invest in companies like Verastem Oncology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Verastem Oncology's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Verastem Oncology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.